Leviqube 500

Levetiracetam 500 mg Tab. FDA-approved as add-on therapy for the treatment of partial seizure with or without secondary generalisation in adults, and reduces the frequency of seizures in patients with refractory partial onset seizures to a significantly greater extent than placebo. Indications: Focal Seizures, Myoclonic Seizures, Primary Generalized Seizures.